Adam Carter

Title: Adam Carter - Innovator in Corticosteroid Responsiveness Modulation

Introduction

Adam Carter is a notable inventor based in Newburyport, MA (US). He has made significant contributions to the field of immunology and inflammation through his innovative methods and compositions. His work focuses on modulating responsiveness to corticosteroids, which has implications for treating various inflammatory diseases.

Latest Patents

Adam Carter holds a patent for "Methods and compositions for modulating responsiveness to corticosteroids." This patent describes a method for administering an agent that antagonizes a factor regulating the production of IFN-.gamma. in combination with a corticosteroid. The goal is to enhance the subject's responsiveness to corticosteroids compared to when a corticosteroid is administered alone. The patent outlines various agents that can be used, including interferon-.gamma. inducing factor antagonists, interleukin-12 antagonists, and inhibitors of caspase family proteases. These methods can be applied in treating a range of inflammatory and immunological diseases.

Career Highlights

Adam Carter is associated with BASF Aktiengesellschaft, where he continues to develop his innovative ideas. His work has led to advancements in pharmaceutical compositions that combine corticosteroids with agents that modulate immune responses. His contributions are vital in the ongoing research and development of treatments for inflammatory conditions.

Collaborations

Adam has collaborated with notable colleagues, including Les Sekut and Tariq Ghayur. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Adam Carter's innovative work in modulating corticosteroid responsiveness represents a significant advancement in the treatment of inflammatory diseases. His contributions continue to impact the field of immunology positively.